BioWorld

Aug. 11, 2003

View Archived Issues

MGI Raises $156.2M Publicly To Fund Oncology Drugs, Purchases

MGI Pharma Inc. netted $146.6 million after selling more shares at a higher-than-projected price in a previously reported public offering.(BioWorld Today) Read More

Genentech, OSI Begin Phase II With Tarceva For Brain Cancer

Read More

Italian Cattle Breeders Clone First Horse; Next? Geldings For Equine Champions, Embryonic Stem Cells

Read More

Pfizer Joins Effort To Limit Sales Of Drugs From Canada

Read More

Other News To Note

Read More